Delivery Order SPE2DB20D3304-SPE2DB25FW6F4
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,577.99, is a delivery order for the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,180.41, is for the delivery of the drug Wegovy 1.7 mg/0.75 ml pen 0.75 ml. The contract is a firm fixed-price delivery order with a completion date of December 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $4,326.97 and is a delivery order for the drug Wegovy 1 mg/0.5 ml pen 0.5 ml. The contract is a firm fixed price contract with an ultimate completion date of March 12, 2025. AmerisourceBergen is the prime contractor, and the contract is not designated as a set-aside. The contract is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,540.65, is for the delivery of the drug Wegovy 1 mg/0.5 ml pen in 0.5 ml quantities. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 11, 2025. This award is not associated with a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $5,551.64 and is for the pharmaceutical product Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract is a firm fixed price agreement with a completion date of December 19, 2023. AmerisourceBergen Drug Corp is the prime contractor, and this award is part of a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,950.68, is for the delivery of Wegovy 1.7 mg/0.75 ml pens. This is a firm fixed-price delivery order contract with a completion date of February 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,787.18, is a delivery order for the drug Wegovy 1 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price contract with an ultimate completion date of April 10, 2025. The contract is not designated as a set-aside and was awarded on April 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,276.00, is for the delivery of the medication Wegovy 2.4 mg/0.75 ml pen. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,163.99, is for the delivery of Wegovy 0.25 mg/0.5 ml pens. The contract is a Firm Fixed Price Delivery Order with a final completion date of February 10, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,816.59, is for the delivery of Wegovy 2.4 mg/0.75 ml pens. This is a firm fixed price delivery order contract with a completion date of March 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...